Astria Therapeutics (ATXS) Q3 2023 Earnings

13NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.72
-0.61
-0.51
-0.4

Details

Expected EPS
-0.49
Actual EPS
-0.63
Surprise EPS
-0.14
Surprise Percent
+28.57%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.63 per share for Q3 2023.

0 Comments

Share your thoughts